BioStem Technologies, Inc.

BSEM · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$564$4,483$15,520
Dep. & Amort.$116$116$78
Deferred Tax$0$0$0
Stock-Based Comp.$1,133$2,128$0
Change in WC$7,358-$2,618-$5,895
Other Non-Cash-$2,620-$36-$1,544
Operating Cash Flow$5,422$4,074$8,159
Investing Activities
PP&E Inv.-$332-$165-$131
Net Acquisitions$0$0$0
Inv. Purchases$0$0$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.$0$0$0
Investing Cash Flow-$332-$165-$131
Financing Activities
Debt Repay.-$920-$102-$102
Stock Issued$0$33$293
Stock Repurch.$0$0$0
Dividends Paid$0$0$0
Other Fin. Act.$0$0$0
Financing Cash Flow-$920-$68$191
Forex Effect$0$0$0
Net Chg. in Cash$4,170$3,841$8,219
Supplemental Information
Beg. Cash$26,673$22,833$14,613
End Cash$30,844$26,673$22,833
Free Cash Flow$5,090$3,909$8,028